Ethical Principles and Publication Policy

Publication ethics: Clinical and Experimental Ocular Trauma and Infection follows International Committee of Medical Journals Editors(ICMJE)Recommendations (http://www.icmje.org/recommendations/) and  Committee on Publication Ethics (COPE) (https://publicationethics.org) international standards for editors and authors. All manuscripts submitted to Clinical and Experimental Ocular Trauma and Infection are screened for plagiarism using the ‘iThenticate’ software. Submitted manuscripts are also subjected for the evaluation of plagiarism, duplicate publication by automatic software. Authors are obliged to acknowledge if they published study results in full or in part in form of abstracts. Results indicating plagiarism may result in manuscripts being returned or rejected.

Plagiarism: To re-publish whole or in part the contents of another author's publication as one's own without providing a reference.

Fabrication: To publish data and findings/results that do not exist. Duplication: Use of data from another publication, which includes re-publishing a manuscript in different languages. Salamisation: To create more than one publication by dividing the results of a study preternaturally. We disapproval upon such unethical practices as plagiarism, fabrication, duplication, and salamisation, as well as efforts to influence the review process with such practices as gifting authorship, inappropriate acknowledgements, and references. Additionally, authors must respect participant right to privacy.


Experimental animal studies should be approved by animal ethic committee according to Guide for the Care and Use of Laboratory Animals (http://oacu.od.nih.gov/regs/guide/guide.pdf), clinical studies, clinical trials and new drug studies should be approved by ethical board. Approval reports sholud be submitted to the journal. Authors must declare that the study was conducted in accordance with international agreements and the Declaration of Helsinki.


The Clinical and Experimental Ocular Trauma and Infection is an independent international journal based on double-blind peer-review principles. The manuscript is assigned to the Editor-in-Chief, who reviews the manuscript and makes an initial decision based on manuscript quality and editorial priorities. Manuscripts that pass initial evaluation are sent for external peer review, and the Editor-in-Chief can evaluate the manuscripts himself/herself or can assign an Associate Editor. Then manuscripts are sent to at least two reviewers. The reviewers must review the manuscript within 4 weeks. The Associate Editor recommends a decision based on the reviewers’ recommendations and returns the manuscript to the Editor-in-Chief. The Editor-in-Chief makes a final decision based on editorial priorities, manuscript quality, and reviewer recommendations. If there are any conflicting recommendations from reviewers, the Editor-in-Chief can assign a new reviewer.